Introduction
Research on embryonic stem cells has generated great intrigue in the scientific community. Many medical researchers consider stem cell-based therapies to have the potential of treating a host of human ailments and yielding a number of medical benefits. distinguished from that used in Canadian courts, which commonly refer to the unborn child at any stage of development as a fetus.
B. Human Reproduction and Stem Cells
The early embryo is comprised of stem cells. These can be characterized as those precursor cells, not yet specialized, that give rise to the more specialized cells of the human body. 12 The biological process by which cells specialize is known as differentiation. It occurs when some of the approximately 80,000 genes in the chromosomes of a cell are inactivated, while the remaining genes are selectively expressed. 13 The function of specific cells in the body will depend on which of these genes are selected for expression. Incidentally, each cell retains the full complement of the DNA that makes up the human genome throughout the differentiation process. It is for this reason that a specialized cell from an adult body can theoretically be used to clone an entire human.
Stem cells can be subdivided into three main categories, depending on their level of differentiation: totipotent, pluripotent and monopotent stem cells. 14 The least differentiated, totipotent stem cells, have unlimited developmental capacity (i.e. the potential to produce an entire human). Thus, the initial single-celled zygote described above is totipotent. In contrast, the inner cell mass of the blastocyst is comprised of pluripotent stem cells, which are more highly differentiated but can potentially specialize into almost any type of tissue. These cells specialize further into monopotent stem cells, which serve as the precursors of specific cell-types having particular functions. They 12 See, e.g. Moffett et al., supra note 6, at 10. 13 See generally Griffiths et al., supra note 2, at 572-605 (discussion on the processes of cell differentiation). include blood stem cells, skin stem cells and stem cells of any of the 214 such cell-types of the human body. 15 It is these pluripotent and monopotent stem cells that researchers hope to isolate, culture and one day apply to therapeutic ends.
C. Stem Cells and In Vitro Fertilization
While the developmental stages outlined above typically occur in the female womb following coitus, the embryos used in embryonic stem cell research are created asexually via in vitro fertilization (IVF). This procedure was first developed for humans in the late 1970s to assist infertile couples with having children. The first step in the process requires obtaining human eggs from a female donor, who has usually been treated with drugs that induce the maturation of multiple follicles in her ovaries. 16 This increases the yield from a single ovulation cycle from one egg to as many as a few dozen eggs per month. The eggs are retrieved either surgically, or by suction through a process known as ultrasound-guided transvaginal aspiration. 17 The eggs are then artificially fertilized in a petri dish with donated sperm.
Biotechnology, through a process known as cryopreservation, now enables the freezing and storage of these artificially created embryos for future use, such as in fertility treatments. The embryos are first treated with a cryoprotectant solution to replace the water in the cells (which would otherwise expand upon freezing, leading to cell rupture). 18 They are then gradually cooled and transferred to liquid nitrogen, where they are stored at a temperature of minus 195 degrees Centigrade. 
D. The Medical Potential of Stem Cells
In vitro fertilization and cryopreservation have provided researchers with a convenient way of obtaining embryos that can supply stem cells for research goals.
Human embryonic stem cells were first isolated in November 1998 by James A. into humans were able to target the human liver. 26 In another experiment, mice that had suffered from heart attacks were injected with blood stem cells. 27 The cells migrated to the damaged regions of the heart, and even produced vessels to supply the new heart muscle with blood. Stem cells have also been shown to develop into brain tissue when injected into rats that had suffered stroke-related brain damage.
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Another exciting potential application of stem cell therapy is in the treatment of spinal injuries. Experiments at John Hopkins University have shown that some rats that had pluripotent stem cells injected into their spinal fluid regained partial leg movement.
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Clearly, there is hope that the same success can be attained with paralyzed humans. Cell therapy is also an especially effective medical treatment because it utilizes the body's own curative abilities. This helps side-step some of the problems associated with transplantation, such as organ rejection. Criminal Code held the same meaning as "human being," which the Code defines as a child that "has completely proceeded, in a living state, from the body of its mother." giving the foetus qua foetus status." 43 It should be noted that some Canadian legislation, primarily in the area of family law, does include unborn children within its definition of "child." 44 Some courts have also found that a fetus is a "child" for purposes of some family law legislation. 45 However, other courts have reached precisely the opposite conclusion. 46 Nor has the fetus ever been constitutionally recognized as a person under the Charter of Rights and Freedoms. Two Ontario courts have found that fetuses are not persons under the Charter. 47 In Borowski, the plaintiff argued that the therapeutic abortion provisions of the Criminal Code were in violation of the constitutional rights of the foetus. However, the Saskatchewan Court of Appeal concluded that a fetus is not included within the definition of "everyone" in section 7, or "every individual" in section 15 of the Charter. A subsequent appeal to the Canadian Supreme Court was declined on the grounds of mootness, resulting from the striking down of all abortion provisions in the Criminal Code in Morgentaler, supra.
B. The Special Circumstances of In Vitro Embryos
The law pertaining the legal status of unborn children in Canada appears to be negligent acts of its mother. In ruling in favor of the mother, the Canadian Supreme
Court pointed out that "it is the biology of the human race which decrees that a pregnant woman must stand in a uniquely different situation to her fetus than any third-party."
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Hence, it is unclear how to apply the principles derived from these cases to help define the legal status of the embryo in the special context of stem cell research. The jurisprudence has generated rules relating to unborn children. The problem, of course, is that this birth event cannot even be contemplated in the case of the unimplanted, in vitro embryos. With in vitro embryos, the complex physical and intensely personal relationship between the embryo and its mother that courts have frequently alluded to is absent. Any legal relationships that exist are essentially only between the embryos and third parties.
This conclusion suggests that the common law rules are rather lacking in providing guidance on those special situations created by artificial reproductive technologies and associated practices such as stem cell research. There is, therefore, a need to elucidate a different standard regarding the legal status of in vitro embryos. This standard will need to address the unique and largely unprecedented circumstances that characterize research on unimplanted embryos. It will also need to contemplate the indirect impact that conferring specific embryonic rights (in any context) may have on women's reproductive autonomy.
C. A Legislative Role in Protecting the Embryo
It will be the role of the legislators to determine the standard that ought to be applied to in vitro embryos. Courts have already suggested that Parliament has a legitimate role in conferring legal protections upon the embryo in clearly specified contexts. In It is feared that such practices can lead to the transfer of animal viruses and other diseases into the human cells. These viruses and diseases, in turn, could afflict any patients that are recipient to those stem cells. Thus, legislation may be appropriate to protect Canadians from these medical risks, at least until such further time that they are either alleviated, or when scientific advances have lowered their probability.
C. Competing Rights i) Reproductive liberty rights:
One of the more obvious rights with which restrictions on embryo research may interfere, and that has already been frequently alluded to, is the right to reproductive liberty. This becomes an issue particularly where restrictions are imposed on the basis of safeguarding the well-being of the embryo. Simply put, "feminists are guarded about movements to accord rights to fetuses, since those rights are frequently invoked by those whose purpose is to regulate how women may behave when they are, or are liable to be, However, courts may consider that the mere knowledge that one has biological offspring somewhere would create a psychological burden that provides sufficient grounds for recognizing such a right. At any rate, this issue is yet another of the many issues to be considered in drafting legislation pertaining to stem cell and embryo research.
ii) Other competing rights:
Another potential right that may be infringed by restrictions on stem cell research is the right to conduct scientific research. Such a right can possibly be read into section 65 competing rights will need to be given by the government when deciding what action to take regarding embryonic stem cell research.
D. Alternatives to Embryonic Stem Cell Research
Whether or not legal restrictions on embryonic stem cell research can be justified will depend partly on the availability of any real alternatives to it. Where such alternatives exist, they would undermine any claims that embryonic stem cell research alone can lead to the medical advances desired. This would make it even more difficult to justify the destruction of human embryos. Thus, an analysis of these more morallyunproblematic alternatives represents an alternate approach to evaluating embryonic stem cell research, one that side-steps the complex ethical debates, and focuses instead on whether such research is in fact necessary. injection of genes from other species, namely humans, into the fertilized egg. For example, the human body's rejection of certain pig organs has already been partially overcome by creating transgenic pigs that express certain human regulatory proteins.
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Another ongoing field of research lies in the use of stem cells that contain human DNA, but are extracted from embryos derived from mammalian eggs. Known as chimeras, these embryos are created by transferring the nucleus of a human cell (where nearly all DNA exists) to a mammalian egg cell whose nucleus has been removed. The procedure, known as somatic cell nuclear transfer, is the same procedure used in wholeorganism cloning (in creating Dolly the sheep, for example). Because they are cloned, the derivative stem cells have the added benefit of providing an exact genetic match for the recipient. The procedure also has practical advantages, given the ample supply of mammalian eggs compared to human eggs. Scientists have already succeeded in using cow and pig eggs to create cow/human and pig/human chimeras. The embryos undergo a few cleavages, although they are still non-viable in the long-term.
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The use of chimeric embryos might side-step some of the ethical concerns associated with experimenting on human embryos. This is because chimeric embryos are technically not human, given that their cellular composition includes both human and animal components. However, the creation of chimeric embryos raises ethical issues relating to the mixing of human DNA and other cellular components with that of other species. Indeed, there is widespread concern that this practice represents an affront to human dignity. There are also safety concerns that arise when the biological products of another species are incorporated into the human body. Further, it recommended the development of "regulated standards in relation to the maximum number of embryos that may be produced, stored and transferred for in vitro fertilization procedures," as well as a prohibition on creating surplus embryos "once egg-storage techniques have been perfected and validated." 95 Bill C-56 will be subject to further review and its passage is expected to take several months. Several more months will be needed before any new regulatory body could begin to function.
Many aspects of the Bill and the Standing Committee's proposals are interesting.
For example, they appear to recognize a moral distinction between embryos that are and are not created for research purposes. They also distinguish between embryos that are older and younger than fourteen days. The proposed requirement of having researchers demonstrate the necessity of experimenting on embryos is also significant. Clearly, this would give new importance to the many potential alternatives to embryonic stem cell research that were outlined earlier.
B. Comparing Proposed Canadian Measures to Those of Other Nations
The passage of Bill C-56 would make Canada the newest in a long list of nations to adopt measures intended to govern stem cell research. Some, including the United One of the most striking problems in the proposed legislation is that it is potentially ambiguous with respect to some of the scientific terms and processes described. Many of the phrases used, such as "alter the genome," are difficult to Another example is that while the text of Bill C-56 appears to renounce the idea of creating an animal/human hybrid, it is ambiguous as to whether the creation of those chimeric clones described earlier in the paper is absolutely prohibited. The legislation defines a chimera as a human embryo "into which a cell of any non-human life form has been introduced" or "that consists of cells of more than one embryo, fetus, or human
being." 99 This definition would not include chimeric clones. They may be encompassed by the prohibition against creating human clones, defined as an embryo with the same nuclear DNA sequence as another human organism. However, an embryo is defined as a human organism, and it is unclear if embryos with cells having human nuclei but animal cellular components can be considered as such. The Standing Committee also found problems with the definitions provided for "gene," "genome," "embryo" and "embryo donor." 100 Clearly, there may be a need for further clarity in the Bill.
The proposed legislation also may fall quickly out-of-touch with both the priorities of developments and changing social priorities. 104 The suggested scheme could perhaps consist of an expanded version of the regulatory regime already contemplated by Bill C-56. In fact, some of the expert witnesses who appeared before the Standing Committee, citing the benefits of regulatory flexibility, recommended the elimination of the prohibited activities category altogether. 105 With a regulatory scheme in place, desired amendments could be achieved more quickly through the usual process for amending regulations, rather than through legislative changes.
Part V. Conclusion
Research on embryonic stem cells has emerged as one of the more controversial areas of medical science. While the medical benefits of the research look promising, the ethical dilemmas of embryo research and destruction remain. Capitalizing on the benefits of stem cell research will require a clarification of the legal status of the embryo and the adoption of clear ethical standards and guidelines.
Canadian jurisprudence currently deems unborn children to be prenatal entities with rights that remain inchoate until birth. It is not clear, however, how the law will treat the in vitro embryo, which has an independent physical existence. The courts have recognized a parliamentary right to legislate on behalf of the embryo in well-defined circumstances. Draft legislation has now been introduced to limit reproductive and genetic technologies.
Any future legislation must remain cognizant of a number of concerns.
Applications of stem cell therapies, due to the primitive state of the technology as well as 104 Id. 105 Building Families, supra note 54.
the nature of the biological processes involved, have numerous safety risks. Canadians need to be protected against these. Legislating protections to the embryo can also indirectly affect female reproductive autonomy, a fact that needs to be addressed. Other rights will also need to be balanced, including any right to scientific research, and the rights of disease-afflicted Canadians to benefit from stem cell therapies. Finally, scientific advances in other fields of biotechnology, such as adult stem cell research, may provide similar benefits to embryonic stem cell research in less morally controversial ways. The significance of these advances will need to be recognized. While Canada's draft legislation goes some way to addressing these issues, certain ambiguities within it suggest that Parliament may not yet have a full understanding or appreciation of this complex technology. Moreover, the use of criminal law may be too rigid a mechanism to apply to this dynamic field. The important ethical, health and social issues that embryonic stem cell research gives rise to make it critical for Canada to establish an effective policy with respect to this technology. With a proper dialogue between scientists, ethicists and jurists, such a policy hopefully will not only be conducive to medical progress, but will also address the legitimate ethical and legal concerns of the Canadian public.
